Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013

Emerg Infect Dis. 2015 Jan;21(1):115-8. doi: 10.3201/eid2101.140256.

Abstract

In 2011, vaccination with a serogroup A meningococcal polysaccharide conjugate vaccine was implemented in 3 of 23 regions in Chad. Cases of meningitis declined dramatically in vaccinated areas, but an epidemic continued in the rest of Chad. In 2012, the remaining Chad population was vaccinated, and the epidemic was halted.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Chad / epidemiology
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Meningitis, Meningococcal / epidemiology
  • Meningitis, Meningococcal / immunology
  • Meningitis, Meningococcal / prevention & control*
  • Meningococcal Vaccines / administration & dosage*
  • Vaccination*
  • Young Adult

Substances

  • Meningococcal Vaccines